IP Library › Granted Patent US 12,256,986
Granted Patent B2
US 12,256,986 · App. 17/378,597 · Granted Mar 25, 2025

Systems and methods for detecting leakage currents in high-frequency ablation systems

Inventors: Seil Oh (Dallas, TX); Binesh Balasingh (Prosper, TX); William Winstrom (Leander, TX); Simran Singh (Richardson, TX)
Assignee: Advanced Neuromodulation Systems, Inc.
A61B18/16A61B18/1206A61B2018/00577
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,256,986
App. No.
17/378,597
Granted
Mar 25, 2025
Kind
B2
Abstract

The present disclosure provides systems and methods for detecting leakage currents in radio-frequency (RF) ablation systems. An RF generator may be configured to disable an electrical return path from a patient to a ground terminal. The RF generator may also be configured to apply an electrical signal to an electrode that is positioned to be in proximity to target tissue of the patient. The RF generator may be further configured to measure a leakage impedance while the electrical return path is disabled and the electrical signal is applied to the electrode. The RF generator may also be configured to control RF ablation therapy based, at least in part, on the measured leakage impedance. Other features are also claimed and described.

Claims (14)

1. A method for controlling a radio-frequency (RF) ablation system, comprising:

disabling an electrical return path from a patient to a ground terminal;

applying an electrical signal to an electrode that is positioned to be in proximity to target tissue of the patient;

measuring a leakage impedance while the electrical return path is disabled and the electrical signal is applied to the electrode; and

controlling RF ablation therapy based, at least in part, on the measured leakage impedance.

2. The method of claim 1 , wherein the controlling of the RF ablation therapy based, at least in part, on the measured leakage impedance includes disabling RF ablation therapy when the leakage impedance is less than a first threshold impedance.

3. The method of claim 1 , wherein the controlling of the RF ablation therapy based, at least in part, on the measured leakage impedance includes disabling RF ablation therapy when a difference between the leakage impedance and a reference impedance is greater than a second threshold impedance.

4. The method of claim 1 , wherein the controlling of the RF ablation therapy based, at least in part, on the measured leakage impedance includes disabling RF ablation therapy, and wherein disabling RF ablation therapy includes preventing a start of RF ablation therapy.

5. The method of claim 1 , wherein the controlling of the RF ablation therapy based, at least in part, on the measured leakage impedance includes disabling RF ablation therapy, and wherein disabling RF ablation therapy includes preventing additional RF ablation therapy after RF ablation therapy has started.

6. The method of claim 1 , wherein the leakage impedance includes impedance observed by an electrical source of the RF ablation system when the electrical return path is disabled.

7. The method of claim 1 , wherein the leakage impedance is measured at least one of:

before a start of RF ablation therapy; or

after RF ablation therapy has started.

8. The method of claim 1 , wherein the leakage impedance is measured periodically after RF ablation therapy has started.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 3, 2022
From: SINGH, SIMRAN
To: ADVANCED NEUROMODULATION SYSTEMS, INC.
Reel/Frame 059795/0139 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 21, 2022
From: BALASINGH, BINESH; WINSTROM, WILLIAM; OH, SEIL
To: ADVANCED NEUROMODULATION SYSTEMS, INC.
Reel/Frame 059670/0552 →
Continuity (2)
Provisional Application 63126288 · Dec 16, 2020
Related Publication 20220183753A1 · Jun 16, 2022
References Cited (5)
US 7736357B2 · Lee, Jr. et al. · 2010 [cited by applicant]
US 8560062B2 · Rittman, III et al. · 2013 [cited by applicant]
US 10342606B2 · Cosman et al. · 2019 [cited by applicant]
US 20130197510A1 · Heckel · 2013 [cited by examiner]
US 20160081740A1 · Heckel · 2016 [cited by examiner]